Alessandro Vitale
Alessandro Vitale
Surgeon, Azienda Ospedaliera Universitaria di Padova
Email verificata su unipd.it - Home page
TitoloCitata daAnno
Prospective validation of the Barcelona Clinic Liver Cancer staging system
U Cillo, A Vitale, F Grigoletto, F Farinati, A Brolese, G Zanus, D Neri, ...
Journal of hepatology 44 (4), 723-731, 2006
3602006
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma
U Cillo, A Vitale, M Bassanello, P Boccagni, A Brolese, G Zanus, P Burra, ...
Annals of surgery 239 (2), 150, 2004
3352004
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?
U Cillo, M Bassanello, A Vitale, FA Grigoletto, P Burra, S Fagiuoli, ...
Journal of hepatology 40 (1), 124-131, 2004
2082004
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
A Vitale, RR Morales, G Zanus, F Farinati, P Burra, P Angeli, AC Frigo, ...
The lancet oncology 12 (7), 654-662, 2011
1182011
Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up‐to‐seven criteria
F D'Amico, M Schwartz, A Vitale, P Tabrizian, S Roayaie, S Thung, ...
Liver transplantation 15 (10), 1278-1287, 2009
1032009
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost‐benefit analysis while awaiting data on sorafenib safety
A Vitale, ML Volk, D Pastorelli, S Lonardi, F Farinati, P Burra, P Angeli, ...
Hepatology 51 (1), 165-173, 2010
1022010
A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation
A Cavallari, U Cillo, B Nardo, F Filipponi, E Gringeri, R Montalti, F Vistoli, ...
Liver transplantation 9 (8), 814-821, 2003
1022003
Intention‐to‐treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria
U Cillo, A Vitale, F Grigoletto, E Gringeri, F D'Amico, M Valmasoni, ...
American Journal of Transplantation 7 (4), 972-981, 2007
1012007
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study
A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ...
Journal of hepatology 62 (3), 617-624, 2015
872015
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma
A Cucchetti, A Vitale, MD Gaudio, M Ravaioli, G Ercolani, M Cescon, ...
American Journal of Transplantation 10 (3), 619-627, 2010
752010
Congenital and childhood myotonic dystrophy: current aspects of disease and future directions
G Ho, M Cardamone, M Farrar
World journal of clinical pediatrics 4 (4), 66, 2015
72*2015
Can hepatic resection provide a long‐term cure for patients with intrahepatic cholangiocarcinoma?
G Spolverato, A Vitale, A Cucchetti, I Popescu, HP Marques, L Aldrighetti, ...
Cancer 121 (22), 3998-4006, 2015
712015
Balancing donor and recipient risk factors in liver transplantation: the value of D‐MELD with particular reference to HCV recipients
AW Avolio, U Cillo, M Salizzoni, L De Carlis, M Colledan, GE Gerunda, ...
American Journal of Transplantation 11 (12), 2724-2736, 2011
682011
Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries
U Baccarani, P Piselli, D Serraino, GL Adani, D Lorenzin, M Gambato, ...
Digestive and Liver Disease 42 (1), 55-60, 2010
612010
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation
A Vitale, F D’Amico, AC Frigo, F Grigoletto, A Brolese, G Zanus, D Neri, ...
Annals of surgical oncology 17 (9), 2290-2302, 2010
602010
Liver transplantation for hepatocellular carcinoma: are the Milan criteria still valid?
ME Schwartz, F D'Amico, A Vitale, S Emre, U Cillo
European Journal of Surgical Oncology (EJSO) 34 (3), 256-262, 2008
592008
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
A Vitale, ML Volk, TM De Feo, P Burra, AC Frigo, RR Morales, L De Carlis, ...
Journal of hepatology 60 (2), 290-297, 2014
552014
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
A Notarpaolo, R Layese, P Magistri, M Gambato, M Colledan, G Magini, ...
Journal of hepatology 66 (3), 552-559, 2017
542017
Development and validation of a new prognostic system for patients with hepatocellular carcinoma
F Farinati, A Vitale, G Spolverato, TM Pawlik, YH Lee, AC Frigo, ...
PLoS medicine 13 (4), e1002006, 2016
522016
Personalized treatment of patients with very early hepatocellular carcinoma
A Vitale, M Peck-Radosavljevic, EG Giannini, E Vibert, W Sieghart, ...
Journal of hepatology 66 (2), 412-423, 2017
512017
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20